Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 51% ± 18% | |
peripheral blood | 18 studies | 52% ± 11% | |
intestine | 15 studies | 45% ± 24% | |
kidney | 9 studies | 40% ± 17% | |
eye | 7 studies | 33% ± 17% | |
lymph node | 6 studies | 51% ± 16% | |
pancreas | 5 studies | 30% ± 9% | |
placenta | 5 studies | 48% ± 23% | |
uterus | 5 studies | 71% ± 19% | |
skin | 5 studies | 50% ± 17% | |
liver | 5 studies | 39% ± 12% | |
bone marrow | 4 studies | 48% ± 18% | |
prostate | 4 studies | 44% ± 9% | |
breast | 4 studies | 66% ± 13% | |
ovary | 3 studies | 43% ± 9% | |
adrenal gland | 3 studies | 43% ± 16% | |
esophagus | 3 studies | 58% ± 20% | |
brain | 3 studies | 27% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 4496.35 | 245 / 245 | 100% | 134.64 | 500 / 502 |
thymus | 100% | 6311.05 | 653 / 653 | 99% | 121.52 | 601 / 605 |
bladder | 100% | 5061.71 | 21 / 21 | 99% | 83.60 | 500 / 504 |
uterus | 100% | 3991.74 | 170 / 170 | 99% | 114.76 | 455 / 459 |
skin | 100% | 8043.07 | 1808 / 1809 | 99% | 56.84 | 468 / 472 |
intestine | 100% | 5205.65 | 964 / 966 | 98% | 74.07 | 517 / 527 |
breast | 100% | 5420.42 | 459 / 459 | 98% | 82.85 | 1093 / 1118 |
esophagus | 100% | 4759.23 | 1443 / 1445 | 98% | 44.89 | 179 / 183 |
stomach | 100% | 5324.20 | 359 / 359 | 97% | 61.70 | 278 / 286 |
lung | 100% | 7116.26 | 577 / 578 | 97% | 53.77 | 1123 / 1155 |
ovary | 100% | 5599.00 | 180 / 180 | 95% | 53.08 | 410 / 430 |
kidney | 100% | 4468.67 | 89 / 89 | 93% | 56.74 | 839 / 901 |
adrenal gland | 100% | 3764.36 | 258 / 258 | 92% | 78.12 | 212 / 230 |
pancreas | 91% | 3056.90 | 300 / 328 | 98% | 87.97 | 175 / 178 |
liver | 98% | 3084.61 | 221 / 226 | 89% | 37.91 | 361 / 406 |
brain | 82% | 1640.55 | 2178 / 2642 | 89% | 38.08 | 627 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 81.70 | 29 / 29 |
spleen | 100% | 5486.51 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 98.27 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 82.51 | 1 / 1 |
peripheral blood | 99% | 6695.40 | 922 / 929 | 0% | 0 | 0 / 0 |
adipose | 99% | 6213.47 | 1193 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 5159.02 | 1322 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 34.62 | 77 / 80 |
heart | 92% | 2751.22 | 792 / 861 | 0% | 0 | 0 / 0 |
muscle | 28% | 434.52 | 222 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048870 | Biological process | cell motility |
GO_0030182 | Biological process | neuron differentiation |
GO_0071774 | Biological process | response to fibroblast growth factor |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | IER2 |
Protein name | Immediate early response gene 2 protein (Protein ETR101) |
Synonyms | PIP92 ETR101 |
Description | FUNCTION: DNA-binding protein that seems to act as a transcription factor . Involved in the regulation of neuronal differentiation, acts upon JNK-signaling pathway activation and plays a role in neurite outgrowth in hippocampal cells (By similarity). May mediate with FIBP FGF-signaling in the establishment of laterality in the embryo (By similarity). Promotes cell motility, seems to stimulate tumor metastasis . . |
Accessions | ENST00000587885.1 ENST00000588173.1 Q9BTL4 ENST00000292433.4 |